Description  Claims  Drawing  Cited references 

CA2525740   [0013] 
CA2676109   [0013] 
CA2619732   [0013] 
WO0157518A   [0063] 

Rapid Commun. Mass Spectrom.   [0013] 
Neoplasia   [0013] 
Cancer Res.   [0013] 
BMC Bioinformatics   [0013] 
Expert Rev. Mol. Diagn.   [0013] 
Biochimica Et Biophysica Acta   [0013] 
Journal of Chromatography B: Biomedical Sciences and Applications   [0013] 
Journal of the National Comprehensive Cancer Network   [0013] 
Journal of the Pancreas   [0013] 
Cancer incidence and mortality in Europe   [0135] 
Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9   [0135] 
Early detection of pancreatic cancer: why, who, and how to screen   [0135] 
Pancreatic cancer--EUS and early diagnosis   [0135] 
Pancreatic cancer screening: state of the art   [0135] 
Altered glycosylation in tumours focused to cancer diagnosis   [0135] 
Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling   [0135] 
Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer   [0135] 
Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9   [0135] 
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology   [0135] 
Choline kinase: an important target for cancer   [0135] 
Molecular prognostic markers in pancreatic cancer: a systematic review   [0135] 
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis   [0135] 
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma   [0135] 
Expression profiling identifies microRNA signature in pancreatic cancer   [0135] 
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients   [0135] 
Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans   [0135] 
Clusterin/apolipoprotein J in human aging and cancer   [0135] 
Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects   [0135] 
Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer   [0135] 
Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus. Cancer Biol Ther 8   [0135] 
A global reorganization of the metabolome in Arabidopsis during cold acclimation is revealed by metabolic fingerprinting   [0135] 
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia   [0135] 
Nontargeted metabolome analysis by use of Fourier Transform Ion Cyclotron Mass Spectrometry   [0135] 
Role of biologically active sphingolipids in tumor growth   [0135] 
Regulation of cell proliferation and apoptosis by bioactive lipid mediators   [0135] 
Sphingolipid metabolizing enzymes as novel therapeutic targets   [0135] 
Sphingolipid targets in cancer therapy   [0135] 
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines   [0135] 
Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy   [0135] 
Bile acids as endogenous etiologic agents in gastrointestinal cancer   [0135]